Is Amphenol (APH) a risky stock?
As of July 21, 2026, Clavix grades Amphenol (APH) B- for risk, a composite score of 65 out of 100 on an A+ to F scale, which puts APH in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind APH's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how APH scores on each, as of July 21, 2026.
What's moving APH's risk right now
Company-specific signals Clavix flags behind APH's current grade, drawn from recent news and filings as of July 21, 2026.
Aware Super bought about $11.18 million of Amphenol shares, while Twin Capital Management and Blackhawk Capital Partners also established new stakes during the first quarter. New positions signal some institutional interest, though they don't by themselves confirm sustained buying demand.
A side-by-side note frames Amphenol as the more resilient pick versus Astera Labs because its connectors serve many end markets rather than relying on a single AI/PCIe 6 story. That breadth could cushion APH if AI-related demand cools.
What a B- grade means
On the Clavix A+ to F scale, APH's composite of 65 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell APH or any security. Grades are risk indicators, not predictions of return. Data may be delayed.